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Accurate prediction of the pathogenic effects of speciﬁc genotypes is important for the design and execution
of clinical trials as well as for meaningful counseling of individual patients. However, for many autosomal
recessive diseases, it can be difﬁcult to deduce the relative pathogenic contribution of individual alleles
because relatively few affected individuals share the same two disease-causing variations. In this study,
we used multiple regression analysis to estimate the pathogenicity of speciﬁc alleles of ABCA4 in patients
with retinal phenotypes ranging from Stargardt disease to retinitis pigmentosa. This analysis revealed quan-
titative allelic effects on two aspects of the visual phenotype, visual acuity (P < 10
23) and visual ﬁeld (P <
10
27). Discordance between visual acuity and visual ﬁeld in individual patients suggests the existence of
at least two non-ABCA4 modifying factors. The ﬁndings of this study will facilitate the discovery of factors
that modify ABCA4 disease and will also aid in the optimal selection of subjects for clinical trials of new
therapies.
INTRODUCTION
A major challenge and opportunity in human genetics is the use
of genetic information to accurately predict the natural history
(clinical course) of heritable disorders. There are at least ﬁve
reasons why this is important to do. First, it allows clinicians
to give a patient a more accurate prognosis than is possible
with clinical methods alone. Second, as new treatments
become available for clinical trial, it helps physicians judge
the risk/beneﬁt ratio of the treatment for each individual
patient. Third, for some diseases, it can help determine the
optimal point in the disease to initiate treatment. Fourth, it
allows clinical trial investigators to balance treatment and
control groups with respect to disease severity—an essential
step if one is to obtain an accurate assessment of an interven-
tion’s value with the lowest possible number of subjects and
in the shortest possible time. Finally, when one can reliably
identify the portion of a given patient’s disease caused by the
disease gene itself, it makes it possible to identify additional
genes and environmental factors that modify the disease in
that patient. Identiﬁcation of a major modifying factor can
serve as the basis for the development of a new treatment.
For dominant diseases, it is often relatively straightforward
to determine the relative pathogenicity of individual alleles
because each affected person harbors only a single allele
and because there are often several affected members of
each family available for study. However, for many recessive
diseases in outbred populations, the majority of affected
patients are compound heterozygotes and the number of
affected individuals in each family is small (1–3). As a
result, the pathogenic effect of one of the alleles in each gen-
otype is somewhat obscured by the other (4).
VariationsinABCA4arethemostcommoncauseofautosomal
recessiveretinaldiseaseinhumans.ABCA4mutationswereorig-
inally discovered in patients with autosomal recessive Stargardt
disease (SD) but shortly thereafter were also found to cause
conedystrophy,cone-roddystrophy(CRD)andretinitispigmen-
tosa (RP), suggesting that a predictable relationship may exist
between ABCA4 genotype and disease severity (5–10).
However, the ABCA4 gene spans more than 100 000 bases and
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(11–14). Most individuals with ABCA4-associated retinal
disease are compound heterozygotes (3,4), making it difﬁcult to
deduce the speciﬁc pathogenic contribution of individual alleles.
In this study, we used multiple regression analysis to deduce
the relative pathogenic effect of 16 speciﬁc alleles of the
ABCA4 gene in patients with molecularly conﬁrmed ABCA4
disease. We also estimated the contribution of non-ABCA4
factors to the disease phenotypes of these individuals.
RESULTS
The primary goal of this study was to determine the relative
pathogenicity of different ABCA4 alleles and we therefore
designed a screening strategy that would efﬁciently identify
a large number of patients with two disease-causing alleles.
A two-step screening method was used to accomplish this.
The ﬁrst step of the screen consisted of an inexpensive, high-
throughput allele-speciﬁc assay designed to detect 32 of the
most common disease-causing ABCA4 variations in the
North American population. The second step consisted of
automated DNA sequence analysis of the ABCA4 coding
sequences of a subset of the individuals found to harbor
only a single disease allele during the ﬁrst step (see Materials
and Methods). Since variations in ABCA4 cause a smaller frac-
tion of RP than CRD or SD, the assay was used to screen 457
patients with RP, 60 patients with CRD, 176 patients with SD
and 272 normal control individuals. One hundred sixty-nine
instances of 61 different disease alleles were observed
among the Stargardt patients compared with only four
instances of three alleles observed among the control individ-
uals (P , 10
210). Similarly, 14 different instances of 10
different alleles were observed among CRD patients (P ,
10
26 compared with controls) and 43 instances of 23 different
alleles were observed among patients with RP (P , 10
24).
Eighty individuals with retinal disease and no control individ-
uals were found to have two disease-causing alleles. Parents or
other family members were available to conﬁrm the phase of
the two alleles in 44 of the 80 unrelated patients with two
alleles and inheritance of one disease allele from each parent
was conﬁrmed in all of these cases. The speciﬁc genotypes
of all individuals found to harbor one or more disease-causing
variants in ABCA4 are shown in the Supplementary Material,
Table.
Two different measurements of visual function were used
to assess the pathogenic contribution of individual ABCA4
alleles: a logMAR transformation of the best-corrected
visual acuity and a volume score calculated from Goldmann
visual ﬁelds (see Materials and Methods). At least one
visual acuity measurement and one visual ﬁeld were available
from 69 of the 80 unrelated patients with two identiﬁed
ABCA4 alleles. The phenotypic correlation between eyes in
these individuals was high (R
2 ¼ 0.91 for the logMAR
acuity and R
2 ¼ 0.94 for the visual ﬁeld volume score). For
51 of the 69 patients with two disease-causing alleles, their
rarer allele was present at least twice in the cohort. Multiple
regression analysis of the genotypic and phenotypic data of
these 51 individuals under an additive model yielded coefﬁ-
cients for each allele that are proportional to their pathogen-
icity (Table 1). We evaluated the statistical signiﬁcance and
clinical relevance of these coefﬁcients in two ways. First,
we placed the 16 alleles of Table 1 in order of their
regression coefﬁcients and tested all 17 possible dichotomous
divisions (i.e. A ¼ mild and B ¼ severe, Table 1) of these
ranked alleles for the ability to reject the null hypothesis
that all alleles have equal effects on the phenotype. This
test revealed that as a group, the A alleles had signiﬁcantly
milder effects than B alleles on both visual acuity (P ,
10
23) and visual ﬁeld (P , 10
27). Next, the regression coef-
ﬁcients for both alleles of each individual were added to
create a genotype pathogenicity score and this score was
compared with each individual’s visual acuity (Fig. 1A)
and visual ﬁeld (Fig. 1B). The R
2 values for both of these
comparisons were moderate, 0.56 for the visual acuity data
and 0.68 for the visual ﬁeld data, suggesting that factors
other than the ABCA4 genotype also play a role in the mag-
nitude of both of these phenotypes in individual patients. If
these non-ABCA4 factors had similar effects on visual
acuity and visual ﬁeld, one would expect these two measure-
ments of visual function to be highly correlated to one
another. However, Figure 2 shows that this is not the case.
The correlation of visual acuity and visual ﬁeld among the
members of this cohort is noticeably less (R
2 ¼ 0.20) than
the correlation of either metric to ABCA4 genotype (Fig. 1).
The magnitude of the non-ABCA4 effects in each individual
can be represented mathematically as residual values in
each of the two multiple regression analyses. Figure 3
shows that there is no correlation (R
2 ¼ 0.06) between the
residual values in this cohort, again suggesting that the
factors that modify ABCA4’s effect on visual acuity are
largely different from the factors that modify the gene’s
effect on visual ﬁeld.
The analyses shown in Table 1 and Figures 1–3 were per-
formed using phenotypic data from a single visit per patient.
The median age of patients with a single visual ﬁeld available
Table 1. Regression coefﬁcients for visual ﬁeld score and visual acuity for the
most common alleles in the cohort of patients with two disease-causing ABCA4
alleles. Alleles are shown in the order of decreasing visual ﬁeld score
coefﬁcients.
Allele VF model Acuity model Occurrences Group
a
Leu2027Phe 22.81 0.14 4 a
Leu1201Arg 22.29 0.16 2 a
Met316fs 20.71 20.15 4 a
Gly1961Glu 18.08 0.26 8 a
Gly863Ala 16.54 0.36 19 a
Pro1380Leu 15.88 0.39 10 a
Ala1038Val 15.19 20.03 12 a
Leu541Pro 10.95 0.08 1 b
Asn965Ser 9.3 0.07 3 b
IVS40 + 5 9.29 0.22 9 b
Val256Val 9.27 0.84 2 b
Phe608Ile 7.24 0.48 2 b
IVS38-10 5.75 0.37 14 b
Arg1108Cys 1.29 0.81 6 b
Leu1430fs 0.37 0.6 2 b
Arg2077Trp 26.89 0.93 4 b
aWhen analyzed as groups, A alleles have signiﬁcantly milder effects on both
visual acuity (P , 10
23) and visual ﬁeld (P , 10
27) than B alleles (see text).
3694 Human Molecular Genetics, 2010, Vol. 19, No. 19Figure 1. Correlation of phenotype and genotype. (A) The correlation (R
2 ¼ 0.56) of the sum of allelic regression coefﬁcients (genotype pathogenicity score)
with the best-corrected visual acuity expressed as the log of the minimum angle of resolution. (B) The correlation (R
2¼ 0.68) of the sum of allelic regression
coefﬁcients with the visual ﬁeld volume score (see Materials and Methods).
Figure 2. Correlation of visual acuity and visual ﬁeld. The average visual acuity measurement from each patient is given on the x-axis and the average visual
ﬁeld measurement from each patient is given on the y-axis. The relatively poor correlation between these values (R
2¼ 0.20) is an indication that non-ABCA4
modifying factors exist that have different effects on these two measures of visual function.
Human Molecular Genetics, 2010, Vol. 19, No. 19 3695for study was 27 years, so for the patients with multiple visits,
the visit that occurred closest to their 27th birthday was the
one included in the analyses. To examine the rate of disease
progression associated with each genotype, one would
ideally have access to multiple visual ﬁeld and/or acuity
measurements from every one of the two-allele patients
taken at evenly spaced intervals spanning a period of
decades. In the absence of such a complete data set, we
attempted to gain a general understanding of the temporal be-
havior of ABCA4 genotypes by plotting the phenotypic
measurements from the cohort of 69 two allele patients as a
function of age. Figure 4A shows the visual ﬁeld data sorted
into quintiles of genotype pathogenicity score. Figure 4B
shows a similar presentation of the visual acuity data. These
ﬁgures show that the majority of the phenotypic difference
among the quintiles is manifest before age 20. Given that
more than 90% of the data in the regression analyses were
obtained from patients older than 20 years, it is not surprising
that we observed little effect of age on the analyses.
Figure 5 shows the ophthalmoscopic appearance and
Goldmann visual ﬁelds of ﬁve patients from the two
allele cohort. In each visual ﬁeld, the colored lines represent
the boundaries (isopters) within which stimuli of various
sizes and intensities were visible to the patient. The red
line indicates the area in which the smallest and dimmest
target (I2e) was visible, whereas the purple line indicates
the area within which the largest and brightest target
(V4e) was seen (see Materials and Methods). Areas of
solid color indicate zones in which a stimulus was not
seen. Three individuals (Fig. 5A–F) are concordant with
the additive pathogenicity model in that they had small
residual values in both the visual acuity and visual ﬁeld
regression analyses (Fig. 3). In contrast, the other two indi-
viduals (Fig. 5G–J) each exhibited substantial departures
from the additive model in both analyses. The patient
shown in Figure 5A and B is typical for individuals with
two relatively mild ABCA4 alleles. The visual acuity and
visual ﬁeld are excellent despite numerous yellow ﬂecks
at the level of the retinal pigment epithelium (RPE)
largely conﬁned to a 3–4 mm ellipse centered on the
fovea. Figure 5C and D depicts an individual that is
typical for patients with one mild and one severe allele.
Flecks are present throughout the posterior pole, a circular
patch of RPE atrophy is centered on the fovea and the
I2e isopter of the visual ﬁeld (red line) is moderately con-
stricted. Figure 5E and F depicts an individual with two
severe alleles. The fundus shows a ‘beaten metal’ appear-
ance in the macula and extensive bone-spicule-like intra-
retinal pigment. The I2e isopter has been lost and some
areas of absolute scotoma are present. Figure 5Ga n dH
depicts a patient with two mild alleles, but visual ﬁelds
that are considerably worse than average for patients with
this genotype pathogenicity score. The RPE is diffusely
thin and the choroidal vasculature is easily visible in
some areas. The I2e isopter is preserved centrally but is
markedly constricted. Figure 5I and J depicts a patient
with two mild alleles but visual acuity that is noticeably
worse than average for patients with this genotype. The
Figure 3. Comparison of residual values from the visual acuity and visual ﬁeld regression analyses. The residual values from the visual acuity regression analysis
are given on the x-axis, while those of the visual ﬁeld regression analysis are given on the y-axis. Individuals represented to the left of the y-axis have visual
ﬁelds that are better than expected for their genotype while those to the right of the y-axis have visual ﬁelds that are worse than expected. Individuals above the
x-axis have visual acuities that are poorer than expected for their genotype, while individuals below the x-axis have visual acuities better than expected. The
residuals of the ﬁve patients depicted in Figure 5 are speciﬁcally labeled. The R
2 value for these data is 0.06.
3696 Human Molecular Genetics, 2010, Vol. 19, No. 19RPE is completely intact, obscuring all details of the under-
lying choroidal vasculature. No ﬂecks are present. There is
a small, dense scotoma centered on ﬁxation but the visual
ﬁelds are otherwise normal.
DISCUSSION
The clinical variation observed among individuals with
disease-causing mutations in the same gene can have at least
ﬁve different non-exclusive explanations: variable structural
and/or functional effects of different alleles on the proteins
they encode, varying biological effects of the altered proteins
on different cell types within affected tissues, effects of one or
more modifying genes (i.e. the genetic background), environ-
mental effects and effects of stochastic events occurring
during development. For diseases that are inherited in an auto-
somal recessive fashion, the situation can be even more com-
plicated. When the majority of affected individuals in a
population are compound heterozygotes—as is the case
when a gene has many alleles and is studied in an outbred
population—it is difﬁcult to distinguish the pathological
effects of the two alleles in a given patient.
In this study, we investigated a group of patients affected
with ABCA4-associated retinal disease, a condition in which
most if not all of the previously mentioned complexities
exist. Using multiple regression analysis, we found that the
majority of the clinical variation among these patients is
traceable to the functional sum of their two alleles. The rela-
tive pathogenicity of the 16 alleles that were observed most
frequently in this cohort is given by the regression coefﬁcients
for each allele summarized in Table 1. As additional patients
are studied using these methods, these values will become
increasingly accurate. However, these numbers, coupled with
the demonstration shown in Figure 1 that the alleles behave
in an additive fashion with respect to visual phenotypes, will
already be useful to investigators who wish to balance treat-
ment and control groups for clinical trials of treatments for
ABCA4-associated retinal disease.
We expected that there would be some
non-ABCA4-related phenotypic variation among the patients
in this cohort and this was most easily seen as the depar-
tures from the additive model lines in Figure 1A and
B. However, we also expected that much of this variation
would affect both visual phenotypes fairly equally. We
were surprised to ﬁnd that the visual acuity and visual
ﬁeld measurements in this cohort had a poorer correlation
to each other than either of them did to ABCA4 genotype
(Fig. 2), suggesting that the most powerful modifying
factors affected the two phenotypes quite differently. This
was most dramatically shown by the complete lack of cor-
relation between the residuals of the regression analyses
(Fig. 3), which represent the magnitudes of the modifying
factors for visual acuity and visual ﬁeld after subtraction
of the effects of the ABCA4 gene itself.
Using the values in Table 1 and Figure 3, we were able to
review the clinical records and retinal photographs of the
patients in the cohort for clues to the nature of these modifying
factors. Three of the patients shown in Figure 5 have small
residual values for both the visual acuity and the visual ﬁeld
regression analyses suggesting that their clinical features are
due almost entirely to the effects of the mutations present in
their ABCA4 genes. The patient with the mildest genotype
exhibits noticeable yellowish deposits at the level of the
RPE but little evidence of photoreceptor cell death. The
patient with the moderate genotype exhibits signiﬁcant
injury of the foveal photoreceptors but insufﬁcient photo-
receptor loss elsewhere to result in bone-spicule-like pigmen-
tation. The patient with the most severe genotype exhibits
widespread loss of both cone and rod photoreceptors in
addition to signiﬁcant injury to the RPE. This sequence of cel-
lular effects—RPE, cones and rods—is compatible with our
current understanding of the function of the ABCA4 protein
(recently reviewed by 14) and the physiology of these three
cell types. ABCA4 encodes an ATP-binding cassette transpor-
ter (15) that couples ATP hydrolysis to the translocation of a
visual cycle intermediate (N-retinylidene-phosphatidylethano-
lamine—N-ret-PE) from the inner leaﬂet of the photoreceptor
disk membrane to the outer leaﬂet (16–18). Reduced function
of this protein allows an additional molecule of
all-trans-retinal to covalently and irreversibly bind to
Figure 4. Visual function over time. (A) The visual acuity values (y-axis)
used for the multiple regression analysis plotted with respect to age. Each indi-
vidual’s genotype score (sum of their allelic coefﬁcients) is indicated by color
with the mildest quintile shown in dark blue and the remaining quintiles in the
increasing order of severity shown in light blue, green, orange and red. (B)
Similar presentation of the visual ﬁeld values. In both panels, better visual
function is at the top of the ﬁgure and poorer visual function is at the
bottom. The majority of the difference in visual function among these ﬁve
quintiles of ABCA4 genotype occurs before age 20.
Human Molecular Genetics, 2010, Vol. 19, No. 19 3697N-ret-PE to form a more toxic diretinal pyridinium compound
known as A2E (16,17,19). The outer segments of rod photo-
receptors turn over completely every 10 days (20), while
cone photoreceptors turn over at about half that rate (21).
The outermost parts of the photoreceptor outer segments are
phagocytosed by the RPE as new photoreceptive elements
are added at the junction of the inner and outer segments.
When the accumulation of A2E is fairly slow, as it would
be with the mildest genotypes, one might expect its concen-
tration in the photoreceptors to remain below a level that
Figure 5. Fundus photographs and Goldman visual ﬁelds of ﬁve patients with ABCA4-associated retinal disease. The patients depicted in the upper 10 panels have
acuitiesandvisualﬁeldsthatarecompletelypredictedbytheadditiveeffectsoftheirABCA4alleles.Thepatientdepictedin(G)and(H)hasbettervisualacuityand
poorervisualﬁeldsthanexpectedforhergenotype,whilethepatientdepictedin(I)and(J)haspoorervisualacuityandbetterﬁeldsthanexpected.(A)and(B)depict
thelefteyeofa27-year-oldwomanwithamildABCA4genotype,20/30acuityandavisualﬁeldscoreof37.5;(C)and(D)depicttherighteyeofan24-year-oldman
withamoderateABCA4genotype,20/160acuityandavisualﬁeldscoreof18.6;(E)and(F)depicttherighteyeofa26-year-oldmanwithasevereABCA4genotype,
10/160 acuity and a visual ﬁeld score of 1.1; (G) and (H) depict the right eye of a 47-year-old woman with a moderate ABCA4 genotype, 20/20 acuity and a visual
ﬁeld score of 8.2; (I) and (J) depict the left eye of a 15-year-old woman with a moderate ABCA4 genotype, 20/160 acuity and a visual ﬁeld score of 43.2.
3698 Human Molecular Genetics, 2010, Vol. 19, No. 19would cause photoreceptor injury while steadily accumulating
in the RPE. With more severe genotypes, one might expect
that the ﬁrst photoreceptor cells to suffer injury would be
those with the slowest turnover (cones). Only with the most
severe genotypes would the rapidly renewed rods accumulate
enough A2E to cause primary (i.e. not secondary to RPE loss)
rod photoreceptor death.
The remaining two patients in Figure 5 are illustrative of the
phenotypic effects of two unrelated modifying factors: one that
modiﬁes acuity with little effect on visual ﬁeld and one that
modiﬁes visual ﬁeld with little effect on acuity. Patient 4 in
Figure 5 has a favorable acuity modiﬁer (protecting the foveal
cones in the face of a moderate ABCA4 genotype) and an unfa-
vorable visual ﬁeld modiﬁer resulting in widespread RPE thin-
ning and patches of RPE atrophy. Patient 5 in Figure 5 is the
reverse of patient 4. In this individual, an unfavorable acuity
modiﬁer results in early loss of foveal cones, while a favorable
visualﬁeldprotectsthe RPEcells from death despitesigniﬁcant
accumulations of intracellular A2E.
The effect of patient age on the phenotype of ABCA4
disease is interesting. Our data show that the majority of the
difference among patients with mild, moderate and severe
genotypes is already evident by age 20 (Fig. 4). Although it
would be tempting to try to infer the temporal behavior of
ABCA4-associated disease based on cross-sectional data,
there are two reasons that this might be somewhat misleading.
First, there is a deﬁnite bias of ascertainment in favor of
patients with reduced visual acuity and/or striking fundus ﬁnd-
ings. Thus, the data points in Figure 4 are unlikely to be a
random sampling of all patients affected with ABCA4 retinal
disease. Second, two of the patients in this cohort with
multiple acuity and ﬁeld measurements showed substantial
worsening after age 40 (data not shown), suggesting that the
population trend of stability after age 20 does not apply to
all patients.
Application of the methods used in this study to additional
cohorts of patients with autosomal recessive disease will
further reﬁne our understanding of the relative pathogenic
effects of speciﬁc alleles. Doing so will improve the prognos-
tic value of genetic testing, contribute to the optimal selection
of subjects in clinical trials and facilitate the discovery of non-
allelic factors that modify the disease phenotype.
MATERIALS AND METHODS
Subjects
All subjects provided written informed consent for this
research study, which was approved by the University of
Iowa Human Subjects Committee.
Figure 5. (Continued)
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RP, 60 patients with CRD and 272 normal control subjects.
Seventeen members of this cohort (13 with SD, 1 with CRD
and 3 with RP) had disease-causing mutations identiﬁed on
one or both alleles in previous studies that employed single-
strand conformational polymorphism analysis as the primary
screening method (3). All patients and control subjects were
ascertained in the outpatient ophthalmology clinic at the Uni-
versity of Iowa. All patients received a complete eye examin-
ation including measurement of Snellen visual acuity, slit
lamp biomicroscopy of the anterior segment and fundus, and
binocular indirect ophthalmoscopy. Most patients had fundus
photography and Goldmann perimetry performed as well.
Molecular characterization of the ABCA4 gene
A multi-platform screening approach was used to genotype
the ABCA4 gene in all 693 research subjects and 272 con-
trols. Thirty-two of the most common disease-causing
ABCA4 variations were selected for the initial screen. The
entire research cohort was assayed for these 32 variations
using a combination of SNPlex, SSCP analysis, TaqMan
and automated DNA sequencing (3). The SNPlex and
TaqMan assays were performed as previously described
(22,23). Fourteen of the variations were compatible with
Applied Biosystems SNPlex allele-speciﬁc assay platform.
Nine variations were screened by SSCP analysis, three
were screened using an Applied Biosystems’ TaqMan assay
and six were screened by automated DNA sequencing. All
CRD and RP patients who had one plausible disease-causing
allele identiﬁed in the ﬁrst tier of screening were assayed by
automated sequencing of the entire coding region of the
ABCA4 gene in an effort to identify their second disease-
causing allele. In addition, Stargardt patients who had one
of the three most common alleles (Gly863Ala, Gly1961Glu
or IVS38-10) were also sequenced through the entire
coding region of the ABCA4 gene.
Visual acuity
The best-corrected visual acuity was recorded in each patient’s
medical record as a Snellen fraction (normal ¼ 20/20). Before
statistical analysis, these values were converted to the logar-
ithm of the minimal angle of resolution (logMAR) by calculat-
ing the base 10 logarithm of the Snellen fraction [e.g.
normal ¼ log(20/20) ¼ 0]. For patients with multiple hospital
visits, the acuity measurements taken closest to the patient’s
27th birthday were used for the statistical analysis. Values
from the left eye and right eye were averaged.
Visual ﬁeld volume scores
Goldmann visual ﬁelds were scanned with a Sharp scanner and
analyzed with ImageJ software (available at http://rsbweb.nih.
gov/ij/) as follows: transparent layers were added to each ﬁeld,
and the isopters of the visual ﬁelds were manually traced onto
these layers. Each isopter was assigned a z-axis value accord-
ing to relative luminous energy of the stimulus (I2e ¼ 100,
I3e ¼ 31.7, I4e ¼ 10, III4e ¼ 0.49, V4e ¼ 0.024, no
detection ¼ 0). The volume scores were calculated by multi-
plying the area of each isopter by its associated z-axis value
and then summing the values for all isopters. For patients
with multiple hospital visits, the visual ﬁeld measurements
taken closest to the patient’s 27th birthday were used for the
statistical analysis. Values from the left eye and right eye
were averaged.
Statistical analyses
The frequencies of disease-causing alleles observed among the
three groups of retinal disease patients were compared with the
frequency in controls using Fisher’s exact test. The phenotype
of each patient was assumed to result from the additive effect
of two alleles and one or more additional factors that were
cumulatively represented by a single residual value for each
subject. The values for the quantitative contribution of each
allele were estimated using a multiple linear regression analy-
sis (24). Speciﬁcally, to dissect the effect of each allele, we
decomposed the mean phenotype of a person whose genotype
consists of allele i and allele j into ai + aj, where ai is the
effect of the i-th allele. To do this, we created a vector Yva
of length 51 containing the average logMAR visual acuities
for each subject, and a 51x16 matrix, X. Each cell of this
matrix, Xij, indicated the number of occurrences of the j-th
allele for each subject i. This system of 51 equations was
solved with multiple linear regression to give estimates of a,
using the statistics program R (available at http://www.
R-project.org). To verify the allelic data, each row of X
summed to 2, and each column summed to the corresponding
number of occurrences of each allele for this cohort. These
calculations were performed in the same manner for Yvol, the
vector of containing each subject’s visual ﬁeld quantitative
phenotype. The estimates of a, the coefﬁcients for each
allele, for both Yva and Yvol are given in Table 1.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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